Energous Corporation — FY2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014; filed March 30, 2015. This is an annual report, not a standalone fourth-quarter filing. Energous was a pre-revenue development-stage company building WattUp, an RF-based wireless charging technology, with a stated strategy to license it to device makers and commercial partners.
Financial results and liquidity
| Metric | FY2014 | FY2013 |
|---|---|---|
| Revenue | $0 | $0 |
| Research and development expense | $12.5 million | $2.1 million |
| General and administrative expense | $5.1 million | $1.2 million |
| Marketing expense | $2.8 million | $0.2 million |
| Loss from operations | $20.4 million | $4.4 million |
| Net loss | $45.6 million | $5.5 million |
| Net loss per share, basic and diluted | $5.75 | $2.11 |
| Cash used in operating activities | $15.6 million | $3.4 million |
| Cash and cash equivalents at year-end | $31.5 million | $2.0 million |
Gross margin and profitability margins are not meaningful because the company reported no revenue. The net loss included a $26.3 million noncash charge from changes in fair value of derivative liabilities; it also recorded a $2.1 million gain on debt extinguishment. The company reported an accumulated deficit of $51.1 million.
Year-end total assets were $33.8 million and current liabilities were $2.5 million. Convertible notes and related derivative liabilities were extinguished when the notes converted to common stock in April 2014; no convertible debt or derivative liabilities remained at year-end. Financing cash flow was $46.8 million, principally from net IPO proceeds of $24.9 million and a December public offering of $21.0 million. Management estimated year-end cash would fund operations into the second quarter of 2016, but said additional financing could be needed to fully execute its plans.
Changes and business developments
- Net loss rose substantially year over year, alongside sharply higher operating expenses as Energous expanded staffing, engineering, patent work, prototype development, and CES demonstrations.
- R&D spending increased by $10.4 million; management attributed the rise to hiring and compensation, components and engineering supplies, patent-related legal costs, and consulting for demonstration units.
- Cash increased following the IPO and December offering, while operating cash use also rose materially.
- The company reported 16 joint development agreements by year-end. In January 2015, it signed a development and licensing agreement with a tier-one consumer electronics company, including a reported $500,000 initial development payment and milestone-based payments. The partner received a time-to-market advantage in specified product categories; the agreement and payment are subsequent to the reporting period.
Outlook, risks, and unusual items
WattUp remained in development: prototypes had been demonstrated in laboratory and partner settings, but the filing cautions that the technology was not optimized and might be too large or costly for commercial products. The filing describes anticipated charging range and capabilities as development goals, not established commercial performance. Management expected losses and negative cash flow to continue and R&D expense to increase.
Major risks include failure to develop an economical, reliable product; inability to obtain required FCC approvals, including expected Part 18 approval; safety concerns; limited market acceptance; competition; dependence on partners and licensees; milestone and performance obligations under the exclusive-advantage agreement; and the need for additional capital. The company said it had more than 125 pending U.S. patent and provisional applications but no issued patents as of the filing’s risk-factor discussion. Management reported effective disclosure controls and internal control over financial reporting; the auditor did not provide an internal-control attestation.
Important facts for investors to verify
- Cash burn, cash balance, and the assumptions behind management’s estimate of runway into Q2 2016; assess subsequent financing needs and dilution.
- Progress against the tier-one partner’s technical milestones, payment terms, product adoption decisions, and scope and duration of exclusivity.
- Regulatory approval status, safety evidence, and whether real-world product performance supports the stated range and charging claims.
- Commercial readiness, production economics, customer demand, and conversion of joint development discussions into binding licenses or revenue.
- Patent prosecution outcomes and any Section 382 limitation that could reduce use of tax-loss carryforwards.